These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 12059123

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Cancer antigen 125 as a marker of ascites in patients with liver cirrhosis].
    Jabłkowski M, Białkowska J, Koktysz R, Bartkowiak J, Stankiewicz W, Dworniak D.
    Pol Merkur Lekarski; 2004; 17 Suppl 1():149-52. PubMed ID: 15603376
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology.
    Sari R, Yildirim B, Sevinc A, Bahceci F, Hilmioglu F.
    Hepatogastroenterology; 2001; 48(42):1616-21. PubMed ID: 11813585
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Peritoneal dialysis in liver disorders.
    Selgas R, Bajo MA, Jimenez C, Sanchez C, Del Peso G, Cacho G, Diaz C, Fernandez-Reyes MJ, De Alvaro F.
    Perit Dial Int; 1996; 16 Suppl 1():S215-9. PubMed ID: 8728196
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical significance of serum CA 125 in patients with chronic liver diseases].
    Kim YS, Kim DY, Ryu KH, Song JH, Kim MS, Jung HS, Park JY, Jung HK, Yoo K, Moon IH, Baek JY.
    Korean J Gastroenterol; 2003 Nov; 42(5):409-14. PubMed ID: 14646578
    [Abstract] [Full Text] [Related]

  • 13. Significance of serum tumor markers carcinoembryonic antigen, CA 19-9, CA 125, and CA 15-3 in pre-orthotopic liver transplantation evaluation.
    Pissaia A, Bernard D, Scatton O, Soubrane O, Conti F, Calmus Y.
    Transplant Proc; 2009 Mar; 41(2):682-4. PubMed ID: 19328956
    [Abstract] [Full Text] [Related]

  • 14. Non-invasive diagnosis and management of chronic liver diseases.
    van Hoek B.
    Forum (Genova); 1999 Mar; 9(2):113-36. PubMed ID: 10385708
    [Abstract] [Full Text] [Related]

  • 15. [Hepatitis B antigen in the serum in chronic liver diseases and malignant hepatoma].
    Libman E, Stojsić S, Marton B, Lemberger J.
    Med Pregl; 1981 Mar; 34(9-10):389-92. PubMed ID: 6281636
    [No Abstract] [Full Text] [Related]

  • 16. CAPD for treatment of ESRD patients with ascites secondary to liver cirrhosis.
    Bajo MA, Selgas R, Jimenez C, Del Peso G, Fernandez-Reyes MJ, Dapena F, De Alvaro F.
    Adv Perit Dial; 1994 Mar; 10():73-6. PubMed ID: 7999868
    [Abstract] [Full Text] [Related]

  • 17. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
    Cedrone A, Covino M, Caturelli E, Pompili M, Lorenzelli G, Villani MR, Valle D, Sperandeo M, Rapaccini GL, Gasbarrini G.
    Hepatogastroenterology; 2000 Mar; 47(36):1654-8. PubMed ID: 11149026
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
    Gessoni G, Manoni F.
    Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.